Ubiquitin immunochemistry as a diagnostic aid for community pathologists evaluating patients who have dementia

Modern Pathology

Volumn 13, Issue 4, 2000, Pages 420-426

  Chu, Charleen T ^a   Caruso, James L ^b,d   Cummings, Thomas J ^c   Ervin, John ^e   Rosenberg, Carlyn ^e   Hulette, Christine M ^c,e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Naval Hospital Pensacola   (United States)

^c Department of Pathology ^*  (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Department of Medicine   (United States)

Author keywords

Alzheimer's disease; Dementia; Immunohistochemistry; Parkinson's disease; Ubiquitin

Indexed keywords

UBIQUITIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; DEMENTIA; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PATHOLOGY, CLINICAL; PHYSICIAN'S PRACTICE PATTERNS; REPRODUCIBILITY OF RESULTS; SENILE PLAQUES; UBIQUITINS;

EID: 0034004683     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880072     Document Type: Article

References (16)

1. Cummings J, Vinters H, Cole G, Khachaturian Z. Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve and treatment opportunities. Neurol 1998;51(Suppl 1):S2-17.
2. Price DL, Sisodia SS, Borchelt DR. Genetic neurodegenerative diseases: The human illness and transgenic models. Science 1998:282:1079-83.
3. Chu CT, Pizzo SV. a2'Macrglu'in' complement, and biologic defense: Antigens, growth factors, microbial proteases, and receptor ligation. Lab Invest 1994;71:792-812.
4. Saunders AM, Strittmatter W, Schmechel D, St. GeorgeHyslop P, Pericak-Vance M, Joo S, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
5. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998;19:357-60.
6. Saunders AM, Hulette CM, Welsh KA, Schmechel DE, Grain B, Burke JR, et al Specificity, sensitivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer disease patients. Lancet 1996; 348:90-3.
7. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: A primer for practicing pathologists. Arch Pathol Lab Med 1993:117:132-44.
8. Mirra SS, Gearing M, McKeel DW, Crain BJ, Hughes JP, Van Belle G, et al Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: A study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J Neuropathol Exp Neurol 1994;53:303-15.
9. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 1991:82:239-59.
10. National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18(Suppl 4):51-2.
11. Hershki A, Ciechanover A. The ubiquitin system. Ann Rev Biochem 1998:67:425-79.
12. Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C. A prospective clinical-neuropathological study of Parkinson's features in Alzheimer's disease: The CERAD experience, Part K. Neurol 1995;45:1991-5.
13. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The consortium to establish a registry for Alzheimer's disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995:45:461-6.
14. Hulette CM, Welsh-Bohmer KA, Crain B, Szymanski MH, Sinclaire NO, Roses AD. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center Experience. Arch Pathol Lab Med 1997:121:615-8.
15. Lloyd B, Brinn N, Burger PC. Silver-staining of senile plaques and neurofibrillary change in paraffin-embedded tissues. J Histotechnol 1985;8:155-6. !
16. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW,: Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996:47:1113-24.